Xeno-Free Strategies for Safe Human Mesenchymal Stem/Stromal Cell Expansion: Supplements and Coatings

被引:69
作者
Cimino, M. [1 ,2 ,3 ]
Goncalves, R. M. [1 ,2 ,4 ]
Barrias, C. C. [1 ,2 ,4 ]
Martins, M. C. L. [1 ,2 ,4 ]
机构
[1] Univ Porto, I3S, Oporto, Portugal
[2] Univ Porto, Inst Engn Biomed INEB, Oporto, Portugal
[3] Univ Porto, Fac Engn, Oporto, Portugal
[4] Univ Porto, ICBAS, Oporto, Portugal
关键词
FETAL BOVINE SERUM; MARROW STROMAL CELLS; HUMAN PLATELET LYSATE; VERSUS-HOST-DISEASE; EX-VIVO EXPANSION; STEM-CELL; BONE-MARROW; OSTEOGENIC DIFFERENTIATION; GROWTH-FACTOR; IN-VITRO;
D O I
10.1155/2017/6597815
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
Human mesenchymal stem/stromal cells (hMSCs) have generated great interest in regenerative medicine mainly due to their multidifferentiation potential and immunomodulatory role. Although hMSC can be obtained from different tissues, the number of available cells is always low for clinical applications, thus requiring in vitro expansion. Most of the current protocols for hMSC expansion make use of fetal bovine serum (FBS) as a nutrient-rich supplement. However, regulatory guidelines encourage novel xeno-free alternatives to define safer and standardized protocols for hMSC expansion that preserve their intrinsic therapeutic potential. Since hMSCs are adherent cells, the attachment surface and cell-adhesive components also play a crucial role on their successful expansion. This review focuses on the advantages/disadvantages of FBS-free media and surfaces/coatings that avoid the use of animal serum, overcoming ethical issues and improving the expansion of hMSC for clinical applications in a safe and reproducible way.
引用
收藏
页数:13
相关论文
共 107 条
[11]
SERUM-FREE CELL-CULTURE [J].
BJARE, U .
PHARMACOLOGY & THERAPEUTICS, 1992, 53 (03) :355-374
[12]
Brindley DA, 2012, REGEN MED, V7, P7, DOI [10.2217/RME.11.112, 10.2217/rme.11.112]
[13]
Brunner D, 2010, ALTEX-ALTERN ANIM EX, V27, P53
[14]
Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions [J].
Castiglia, Sara ;
Mareschi, Katia ;
Labanca, Luciana ;
Lucania, Graziella ;
Leone, Marco ;
Sanavio, Fiorella ;
Castello, Laura ;
Rustichelli, Deborah ;
Signorino, Elena ;
Gunetti, Monica ;
Bergallo, Massimiliano ;
Bordiga, Anna Maria ;
Ferrero, Ivana ;
Fagioli, Franca .
CYTOTHERAPY, 2014, 16 (06) :750-763
[15]
Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction [J].
Chen, SL ;
Fang, W ;
Ye, F ;
Liu, YH ;
Qian, J ;
Shan, S ;
Zhang, J ;
Zhao, RCH ;
Liao, LM ;
Lin, S ;
Sun, JP .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (01) :92-95
[16]
Effects of Human Mesenchymal Stem Cell Transplantation Combined with Polymer on Functional Recovery Following Spinal Cord Hemisection in Rats [J].
Choi, Ji Soo ;
Leem, Joong Woo ;
Lee, Kyung Hee ;
Kim, Sung-Soo ;
Suh-Kim, Haeyoung ;
Jung, Se Jung ;
Kim, Un Jeng ;
Lee, Bae Hwan .
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2012, 16 (06) :405-411
[17]
PREPARATION AND PROPERTIES OF SERUM AND PLASMA PROTEINS .4. A SYSTEM FOR THE SEPARATION INTO FRACTIONS OF THE PROTEIN AND LIPOPROTEIN COMPONENTS OF BIOLOGICAL TISSUES AND FLUIDS [J].
COHN, EJ ;
STRONG, LE ;
HUGHES, WL ;
MULFORD, DJ ;
ASHWORTH, JN ;
MELIN, M ;
TAYLOR, HL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1946, 68 (03) :459-475
[18]
The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to the cell substrate [J].
Curran, Judith M. ;
Chen, Rui ;
Hunt, John A. .
BIOMATERIALS, 2006, 27 (27) :4783-4793
[19]
The road to providing human embryo stem cells for therapeutic use: the UK experience [J].
De Sousa, Paul A. ;
Galea, George ;
Turner, Marc .
REPRODUCTION, 2006, 132 (05) :681-689
[20]
Design of Experiments Approach to Engineer Cell-Secreted Matrices for Directing Osteogenic Differentiation [J].
Decaris, Martin L. ;
Leach, J. Kent .
ANNALS OF BIOMEDICAL ENGINEERING, 2011, 39 (04) :1174-1185